El ensayo clínico en fase 1 liderado por el IDIBELL y el ICO muestra que la administración del virus VCN-01 es viable y una posible nueva herramienta en el tratamiento del cáncer de páncreas avanz...
Read more
There is evidence on the effects of diet on the risk of developing pancreatic cancer. There may be a link between pro-inflammatory diets and the possibility of developing pancreatic cancer. Although t...
Read more
The biopharmaceutical company Ability Pharmaceuticals, SL today announced the inclusion of the first patients in a phase 2b clinical trial with its novel autophagy-inducer anticancer compound ABTL0812...
Read more
Nano-based drug delivery and anti-cancer therapy have shown promise in recent years as potential novel weaponry in the current arsenal of anti-cancer technologies. Nano-driven therapeutics involves th...
Read more
As a notoriously ‘silent’ disease in terms of identifiable symptoms, pancreatic cancer generally manifests itself at late and advanced stages, with only 20% of patients as candidates for curati...
Read more
The project aims to identify high-risk populations for pancreatic cancer, to include them in screening and early detection interventions so as to try to increase patients' survival rates
Read more
CNIO researchers discover that healthy cells suppress inflammation unless it is required. This finding suggests new strategies to improve the prevention of pancreatic cancer. The research is published...
Read more
Ability Pharmaceuticals, a drug development biopharmaceutical company specialized in oncology, announced today that has received orphan-drug designation (ODD) for ABTL0812 from the US Food and Drug Ad...
Read more
The research comes as the results of an earlier European study which showed in animal models the efficacy of a therapeutic nanoconjugate against pancreatic cancer. Based on these results, the research...
Read more
A project conducted by the Hospital del Mar Medical Research Institute (IMIM) and the UAB to investigate whether certain pesticides and other environmental toxins contribute to pancreatic cancer has b...
Read more
The combination of TTFields and chemotherapy did demonstrate a delay in tumour growth compared to the animals treated only with chemotherapy (47% average relative reduction of tumour growth)
Read more
Pancreatic cancer is rare, but it is one of the most deadly cancers with the highe st mortality rates, and one of the lowest 5 -‐ year survival rates approaching 15 ‐ 20%
Read more
A new technique allows the design of solid materia...
El estudio realizado sobre una muestra significati...
Dámaso Molero: “There are great opportunities in Latin America for ...
Un equipo de investigadores del CSIC ha descubierto que la saliva del ...
